J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

Poplar Therapeutics, Inc. announced its launch today highlighting its $50 million Series A financing led by SR One, Vida Ventures and Platanus. Previously known as Phylaxis Bioscience, Poplar ...

Keeping your skin well moisturized helps to prevent cracks and fissures in your skin that could lead to a worsening rash, itching, or infection. Where do signs, such as rashes or dryness and itch, ...

Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...

If you or a loved one has been diagnosed with atopic dermatitis, the most common form of eczema, you can use this list of common terms to navigate treatment and manage the condition. allergen A ...

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...

Atopic dermatitis (AD) is a chronic inflammatory skin disease predominantly mediated by T helper cells. While numerous adaptive immune mechanisms in AD pathophysiology have been elucidated in detail, ...

Atopic dermatitis (AD) is a type of eczema, a condition that makes skin dry, red, and itchy. There are many ways to tame its symptoms, from creams that control itching to light therapy. But about half ...

Atopic dermatitis, the most common form of eczema, can lead to dry, itchy, and inflamed skin. It often comes and goes in flares. Atopic dermatitis affects people of all skin tones, but it doesn't ...

Detailed price information for Apogee Therapeutics Inc (APGE-Q) from The Globe and Mail including charting and trades.